Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression
about
The Role of microRNAs in the Pathogenesis of Herpesvirus InfectionThe KSHV RNA regulator ORF57: target specificity and its role in the viral life cycleModulation of the Translational Landscape During Herpesvirus InfectionKaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA: a structural scaffold for nuclear, cytoplasmic and viral proteins.IL-6 in inflammation, immunity, and diseaseAttenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicingPAN's Labyrinth: Molecular biology of Kaposi's sarcoma-associated herpesvirus (KSHV) PAN RNA, a multifunctional long noncoding RNA.Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 proteinStability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.Multiple regions of Kaposi's sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15.KSHV ORF57, a protein of many facesStability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1.Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolismLooking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint.KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging ConceptsHSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro.Mammalian alphaherpesvirus miRNAs.Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.The physiological impact of microRNA gene regulation in the retina.Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor.Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation.Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA.Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2.Complexities of gammaherpesvirus transcription revealed by microarrays and RNAseq.Cell-based screening assay for antiviral compounds targeting the ability of herpesvirus posttranscriptional regulatory proteins to stabilize viral mRNAs.A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infectionmiR-191 and miR-135 are required for long-lasting spine remodelling associated with synaptic long-term depressionThe many roles of the highly interactive HSV protein ICP27, a key regulator of infection.KSHV Rta Promoter Specification and Viral Reactivation.The Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein and Its Multiple Roles in mRNA Biogenesis.Diverse virus-host interactions influence RNA-based regulation during γ-herpesvirus infection.Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.Kaposi's sarcoma-associated herpesvirus ORF57 protein: exploiting all stages of viral mRNA processing.Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA.Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity.Identification of miR-1293 potential target gene: TIMP-1.
P2860
Q26748350-87E9BA6B-324D-4E88-956A-BA381230AAFDQ26771969-9153FF06-B3E3-4A59-8CCF-18F8CC5A74B2Q28078469-BC25A7B1-5E54-486D-864F-5598F30D39C4Q33878627-8259C206-1C24-4DE0-8FE0-5A1A777575C7Q34248105-05B4F077-8C07-42C0-BA54-A1369FAEB5A8Q34363904-63D74DF2-5A2A-4DE6-86D9-B9531484413FQ34580795-E4D7B363-3B43-49A2-A7F4-68A0597D7E4AQ34580878-6C8C6865-A2D2-4510-BBB2-E231926F54DEQ34991371-A5C7B175-63D9-4DF8-AA5F-E2A9AE3F95ACQ35111060-3E103F5C-7083-4424-850D-5FEA0035E52EQ35111102-710C49BC-3BAC-4FC7-B56F-7717DD7A50DAQ35159983-313EBCD4-06A9-4705-9349-781CEE2A9A84Q35160000-F5B8CD23-D248-439C-9D0C-B6ADE6B1FDF2Q35479911-C518572A-AA64-4170-AA27-3F5BA5C67A73Q35550033-21D2F1CF-EA84-4A57-9D67-A43B622B027DQ35566776-DEE8F3F1-A12B-4CAF-BB12-CA740524A553Q35671861-105BE821-B4D5-4820-AF0E-561F8DB7F4D7Q35810446-4D880767-B5E1-47AE-B456-60BEE1802947Q35896981-81ECD008-C6EF-432B-964C-44E6AE180CC5Q36057726-518D1F92-EFFE-4E99-96AC-69B53DDE2E98Q36153930-7FBCE3F4-7762-4F64-8A7D-EAD0392CBBFEQ36238203-C0A3F851-9BA0-4F38-B16E-6A9EAD7567CFQ36397547-269FD631-8248-49CA-9F05-661034103C46Q36483206-AB0AE18D-AAE7-4767-9B91-A27D643368D3Q36506808-A082600C-B470-42C7-9AA3-C2B359FC90A6Q36518307-3A40DB2C-ECA6-40E9-9F77-310D00344980Q37018410-BA5BA54E-6945-4CF5-82EA-C69DC38B77ABQ37252895-909E1866-73BC-4961-9B15-57D950998987Q37308761-1CB5A68B-0B1D-445D-A3E2-9FBBA25A1141Q37633174-E483FCAF-7E63-4E0B-8D94-94AA3292124CQ37955947-B4D4DDCC-EE0F-441D-B8BA-E64CD10F149DQ37986049-723440EF-8542-4076-8A14-86597B837D6AQ37987926-0BE7BEFC-A876-48FC-9FFE-ED4ABEEE3D5FQ38017467-CE57C2AC-BE97-49F3-A764-95DC050823F6Q38058508-307C50F4-33E8-41F7-AB12-8526360C0790Q38125077-9D7A4462-7FC6-4F53-ACB0-54378CA126C5Q38449592-733E4871-4805-4157-9F28-468664319C38Q38535445-21DB771E-B287-418B-BFBD-DF79B62B8D75Q38542124-F429F416-2876-4FA6-97A6-D933E3BF15E8Q39110512-1CCFE421-E6F1-4B76-9A73-9BFB9C0C1863
P2860
Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@ast
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@en
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@nl
type
label
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@ast
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@en
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@nl
prefLabel
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@ast
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@en
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@nl
P2093
P2860
P356
P1433
P1476
Kaposi's sarcoma-associated he ...... microRNA-mediated suppression
@en
P2093
Jeong-Gu Kang
Michael Kruhlak
Natalia Pripuzova
Shu-Yun Le
Vladimir Majerciak
Zhi-Ming Zheng
P2860
P304
P356
10.1128/JVI.02144-10
P407
P577
2011-01-05T00:00:00Z